Unclaimed brand
Discover the ELAINE Studies: investigating an oral drug, lasofoxifene, in women and men with locally advanced or metastatic ER+/HER2- breast cancer expressing an ESR1 mutation.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#045398
Congress Blue
4, 83, 152
208, 95, 31
97, 45, 0, 40
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
#FACEA8
Corvette
250, 206, 168
28, 89, 82
0, 18, 33, 2
Sermonix Pharmaceuticals is at the forefront of cancer treatment research, focusing on the innovative ELAINE studies, which investigate the efficacy and safety of lasofoxifene for patients with estrogen receptor-positive (ER+)/HER2-negative metastatic breast cancer expressing an ESR1 mutation. The ELAINE trials, comprising ELAINE-1, ELAINE-2, and the currently recruiting ELAINE-3, aim to assess this novel oral drug's potential to improve outcomes for those affected by this challenging condition.
Lasofoxifene is distinguished as the only investigational targeted endocrine agent specifically targeting ESR1 mutations, which can lead to treatment resistance in patients. By blocking estrogen receptors that fuel tumor growth, lasofoxifene seeks to slow disease progression and enhance quality of life.
With ongoing clinical trials across the United States, Europe, Japan, Israel, and Canada, Sermonix is committed to pioneering solutions that address the needs of individuals living with metastatic breast cancer and advancing the field of oncology through aimed research and innovative therapies.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
How do I download the Sermonix Pharmaceuticals logo?
What are Sermonix Pharmaceuticals' brand colors?
The Sermonix Pharmaceuticals color palette uses the hex codes #045398, #000000 and #FACEA8.
The Sermonix Pharmaceuticals name, logos and brand assets are trademarks of Sermonix Pharmaceuticals and its affiliates. Brandfetch isn't affiliated with or endorsed by Sermonix Pharmaceuticals. Their use is subject to Sermonix Pharmaceuticals's brand guidelines.
